Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).

Autor: El Omri H; Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha 3050, Qatar., Padmanabhan R; College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar., Taha RY; Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha 3050, Qatar., Kassem N; Pharmacy Department NCCCR, Hamad Medical Corporation, Doha, Qatar., Elsabah H; Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha 3050, Qatar., Ellahie AY; Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha 3050, Qatar., Santimano AJJ; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha 3050, Qatar., Al-Maslamani MA; Communicable Disease Center, Hamad Medical Corporation, Qatar., Omrani AS; Communicable Disease Center, Hamad Medical Corporation, Qatar., Elomri A; College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar., El Omri A; Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha 3050, Qatar. Electronic address: AElOmri@hamad.qa.

Publikováno v: Journal of infection and public health [J Infect Public Health] 2024 Jan; Vol. 17 (1), pp. 152-162. Date of Electronic Publication: 2023 Nov 21.

Acute Myeloid Leukemia in Qatar (2010-2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes.

Autor: El Omri H; Medical Oncology-Hematology Department, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar., Taha RY; Medical Oncology-Hematology Department, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar., Elomri A; Division of Engineering Management and Decision Sciences, College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar., Kacem N; Clinical Pharmacy, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Elsabah H; Medical Oncology-Hematology Department, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar., Ellahie AY; Medical Oncology-Hematology Department, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar., Gamil A; Medical Oncology-Hematology Department, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar., Ibrahim F; Hematopathology Laboratory, Hamad Medical Corporation, Doha, Qatar., Soliman DSA; Hematopathology Laboratory, Hamad Medical Corporation, Doha, Qatar., El Akiki SJL; Cytogenetic and Molecular Laboratory, Hamad Medical Corporation, Doha, Qatar., Nawaz Z; Cytogenetic and Molecular Laboratory, Hamad Medical Corporation, Doha, Qatar., Al Sabbagh A; Hematopathology Laboratory, Hamad Medical Corporation, Doha, Qatar., El Omri A; Center of Excellence in Bionanoscience Research and Genomics and Biotechnology Section and Research Group, Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

Publikováno v: Frontiers in genetics [Front Genet] 2020 Jun 17; Vol. 11, pp. 553. Date of Electronic Publication: 2020 Jun 17 (Print Publication: 2020).